Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLipella Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.28 | -$1.28 | -$1.28 |
| Q2 2024 | 1 | -$0.96 | -$0.96 | -$0.96 |
| Q3 2024 | 1 | -$10.33 | -$10.33 | -$10.33 |
| Q4 2024 | 1 | -$2.43 | -$2.43 | -$2.43 |
Lipella Pharmaceuticals Inc. Earnings Date And Information
Lipella Pharmaceuticals Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-1.29 earnings per share for the quarter, missing analysts' consensus estimates of $-0.96 by $0.33. The company had revenue of 80,380 for the quarter and had revenue of 449,617 for the year. Lipella Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-0.77 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Lipella Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Lipella Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.96 | -$1.29 | -0.33 | $80,000 | $80,380 |
| 08/13/2024 | Q2 2024 | -$0.96 | -$0.12 | 0.84 | $136,000 | $136.43 M |
| 05/09/2024 | Q1 2024 | -$1.28 | -$0.16 | 1.12 | $145,880 | |
| 02/27/2024 | Q4 2023 | -$0.11 | $120,842 | |||
| 11/14/2023 | Q3 2023 | -$0.23 | $104.05 M | |||
| 08/14/2023 | Q2 2023 | -$0.27 | $106.68 M | |||
| 05/12/2023 | Q1 2023 | $1.77 | $118,048 | |||
| 03/31/2023 | Q4 2022 | -$0.06 | $151,007 | |||
| 09/29/2022 | Q3 2022 | -$0.12 | $0 | |||
| 06/29/2022 | Q2 2022 | -$0.14 | $0 | |||
| 03/30/2022 | Q1 2022 | -$0.13 | $33,149 | |||
| 12/30/2021 | Q4 2021 | -$0.07 | $25,881 | |||
| 09/29/2021 | Q3 2021 | -$0.09 | $0 | |||
| 06/29/2021 | Q2 2021 | -$0.06 | $148,968 | |||
| 03/30/2021 | Q1 2021 | -$0.11 | $84,498 |
Lipella Pharmaceuticals Inc. Earnings: FAQ's
When is Lipella Pharmaceuticals Inc.'s earnings date?
Lipella Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to Lipella Pharmaceuticals Inc.'s earnings conference
call?
The conference call for Lipella Pharmaceuticals Inc.'s latest earnings report can be listened to online.
How can I read Lipella Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Lipella Pharmaceuticals Inc.'s latest earnings report can be read online.
How much revenue does Lipella Pharmaceuticals Inc. generate each year?
Lipella Pharmaceuticals Inc. (:LIPO) has a recorded annual revenue of $449,617.
How much profit does Lipella Pharmaceuticals Inc. generate each year?
Lipella Pharmaceuticals Inc. (:LIPO) has a recorded net income of $449,617. Lipella Pharmaceuticals Inc. has generated $-0.77 earnings per share over the last four quarters.
What is Lipella Pharmaceuticals Inc.'s price-to-earnings ratio?
Lipella Pharmaceuticals Inc. (:LIPO) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is 0.